SCHEMBL5887048

SCHEMBL5887048

Cc1nc(N2CCN(C(=O)c3cccnc3)CC2)nc2c1ccc(=O)n2-c1ccc(C(=O)NCc2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
HTT P42858 2/20 0.42
KHK P50053 1/20 0.42
NAMPT P43490 3/20 0.42
MMP12 P39900 1/20 0.41
KLKB1 P03952 1/20 0.41
KLK1 P06870 1/20 0.41
ALDH1A1 P00352 3/20 0.41
PRKAA2 P54646 1/20 0.41
AKT1 P31749 2/20 0.40
AKT2 P31751 2/20 0.40
AKT3 Q9Y243 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5887085 0.96 HTT (0.41) MAPTHTTKHKNAMPTMMP12
SCHEMBL5887675 0.93 SLC6A7 (0.44) MAPTKLKB1ALDH1A1PRKAA2SMN1; SMN2
SCHEMBL5887505 0.93 MGAM (0.41) MAPTHTTKHKNAMPTMMP12
SCHEMBL5887563 0.92 EPHX2 (0.42) MAPTHTTNAMPTALDH1A1HDAC3
SCHEMBL5887646 0.92 MAPK1 (0.40) MAPTHTTNAMPTKLKB1KLK1
SCHEMBL5886777 0.89 NAMPT (0.46) MAPTHTTNAMPTALDH1A1SMN1; SMN2
SCHEMBL5887334 0.89 ALDH1A1 (0.44) MAPTHTTNAMPTALDH1A1SMN1; SMN2
SCHEMBL5886882 0.88 MAPT (0.43) MAPTHTTALDH1A1SMN1; SMN2NPSR1
SCHEMBL5887394 0.88 ACHE (0.44) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL5886700 0.87 MGLL (0.42) MAPTKLKB1ALDH1A1SMN1; SMN2SLC6A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP MAPT 1614/4885HTT 1319/4885KHK 3346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.